Epigenetics and the Transition from Acute to Chronic Pain

Pain Medicine (United States)

Volumn 13, Issue 11, 2012, Pages 1474-1490

  Buchheit, Thomas ^a   Van de Ven, Thomas ^a   Shaw, Andrew ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

DNA Methylation; Epigenetics; Histone Deacetylase Inhibitors; Pain; RNA Interference

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOSINE; DIAMORPHINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; ENDOTHELIN RECEPTOR; GIVINOSTAT; GLUCOCORTICOID; GLUCOSAMINE; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; METHIONINE; METHYL CPG BINDING PROTEIN 2; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; OPIATE RECEPTOR; PROENKEPHALIN; PURINERGIC P2X3 RECEPTOR; SODIUM CHANNEL NAV1.7; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UNTRANSLATED RNA; VALPROIC ACID; VANILLOID RECEPTOR 1; VORINOSTAT;

ACETYLATION; ARTICLE; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLONING; COMPLEMENT ACTIVATION; CPG ISLAND; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEACETYLATION; DEGENERATIVE DISEASE; DISEASE SEVERITY; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; EPIGENETICS; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; GENE SILENCING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; INFLAMMATORY DISEASE; LONG TERM CARE; NEUROPATHIC PAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAIN; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; POLYMERASE CHAIN REACTION; PROTEIN RNA BINDING; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SPINAL GANGLION;

EID: 84869155516     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01488.x     Document Type: Article

References (184)

1. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell 2009;139(2):267-84.
2. Schuler GD, Boguski MS, Stewart EA, etal. A gene map of the human genome. Science 1996;274(5287):540-6.
3. Yuan R, Zhang X, Deng Q, etal. Two novel SCN9A gene heterozygous mutations may cause partial deletion of pain perception. Pain Med 2011;12(10):1510-4.
4. Zubieta JK, Heitzeg MM, Smith YR, etal. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003;299(5610):1240-3.
5. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: Risk factors and prevention. Lancet 2006;367(9522):1618-25.
6. Javierre BM, Fernandez AF, Richter J, etal. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010;20(2):170-9.
7. Altman D, Lundholm C, Milsom I, etal. The genetic and environmental contribution to the occurrence of bladder pain syndrome: An empirical approach in a nationwide population sample. Eur Urol 2011;59(2):280-5.
8. Michalowicz BS, Pihlstrom BL, Hodges JS, Bouchard TJ, Jr. No heritability of temporomandibular joint signs and symptoms. J Dent Res 2000;79(8):1573-8.
9. Villeneuve LM, Natarajan R. Epigenetic mechanisms. Contrib Nephrol 2011;170:57-65.
10. Sassone-Corsi P. Unique chromatin remodeling and transcriptional regulation in spermatogenesis. Science [Review] 2002;296(5576):2176-8.
11. Guo JU, Ma DK, Mo H, etal. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 2011;14(10):1345-51.
12. Chwang WB, Arthur JS, Schumacher A, Sweatt JD. The nuclear kinase mitogen- and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation. J Neurosci 2007;27(46):12732-42.
13. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: Do pain and memory share similar mechanisms? Trends Neurosci 2003;26(12):696-705.
14. Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science 2008;319(5871):1827-30.
15. Cubas P, Vincent C, Coen E. An epigenetic mutation responsible for natural variation in floral symmetry. Nature 1999;401(6749):157-61.
16. Ng SF, Lin RC, Laybutt DR, etal. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 2010;467(7318):963-6.
17. Coppede F. The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. Mutat Res 2009;682(1):54-70.
18. Bell CG, Beck S. The epigenomic interface between genome and environment in common complex diseases. Brief Funct Genomics 2010;9(5-6):477-85.
19. McEwen BS, Eiland L, Hunter RG, Miller MM. Stress and anxiety: Structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2012;62(1):3-12.
20. Kiguchi N, Kobayashi Y, Maeda T, etal. Epigenetic augmentation of the MIP-2/CXCR2 axis through histone H3 acetylation in injured peripheral nerves elicits neuropathic pain. J Pharmacol Exp Ther 2011;340(3):577-87.
21. Uchida H, Sasaki K, Ma L, Ueda H. Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury. Neuroscience 2010;166(1):1-4.
22. Katz J, Poleshuck EL, Andrus CH, etal. Risk factors for acute pain and its persistence following breast cancer surgery. Pain 2005;119(1-3):16-25.
23. Caumo W, Schmidt AP, Schneider CN, etal. Preoperative predictors of moderate to intense acute postoperative pain in patients undergoing abdominal surgery. Acta Anaesthesiol Scand 2002;46(10):1265-71.
24. Bosmans JC, Geertzen JH, Post WJ, van der Schans CP, Dijkstra PU. Factors associated with phantom limb pain: A 31/2-year prospective study. Clin Rehabil 2010;24(5):444-53.
25. Dijkstra PU, Geertzen JH, Stewart R, van der Schans CP. Phantom pain and risk factors: A multivariate analysis. J Pain Symptom Manage 2002;24(6):578-85.
26. Ephraim PL, Wegener ST, MacKenzie EJ, Dillingham TR, Pezzin LE. Phantom pain, residual limb pain, and back pain in amputees: Results of a national survey. Arch Phys Med Rehabil 2005;86(10):1910-9.
27. Nikolajsen L, Ilkjaer S, Kroner K, Christensen JH, Jensen TS. The influence of preamputation pain on postamputation stump and phantom pain. Pain 1997;72(3):393-405.
28. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010;465(7299):721-7.
29. Bollati V, Baccarelli A, Hou L, etal. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007;67(3):876-80.
30. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis [Review]. 2010;31(1):27-36.
31. Sananbenesi F, Fischer A. The epigenetic bottleneck of neurodegenerative and psychiatric diseases. Biol Chem 2009;390(11):1145-53.
32. Schmitter M, Keller L, Giannakopoulos N, Rammelsberg P. Chronic stress in myofascial pain patients. Clin Oral Investig 2010;14(5):593-7.
33. Rieley MB, Stevenson DA, Viskochil DH, etal. Variable expression of neurofibromatosis 1 in monozygotic twins. Am J Med Genet A 2011;155A(3):478-85.
34. Torres de Heens GL, Loos BG, van der Velden U. Monozygotic twins are discordant for chronic periodontitis: Clinical and bacteriological findings. J Clin Periodontol 2010;37(2):120-8.
35. Ballestar E. Epigenetics lessons from twins: Prospects for autoimmune disease. Clin Rev Allergy Immunol 2010;39(1):30-41.
36. Doehring A, Geisslinger G, Lotsch J. Epigenetics in pain and analgesia: An imminent research field. Eur J Pain 2011;15(1):11-6.
37. Lacroix-Fralish ML, Tawfik VL, Tanga FY, Spratt KF, DeLeo JA. Differential spinal cord gene expression in rodent models of radicular and neuropathic pain. Anesthesiology 2006;104(6):1283-92.
38. Tajerian M, Alvarado S, Millecamps M, etal. DNA methylation of SPARC and chronic low back pain. Mol Pain 2011;7:65.
39. Ma W, Bisby MA. Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res 1998;797(2):243-54.
40. Jin X, Gereau RWt. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 2006;26(1):246-55.
41. Li Z, Proud D, Zhang C, Wiehler S, McDougall JJ. Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception. Arthritis Rheum 2005;52(10):3210-9.
42. Porreca F, Tang QB, Bian D, etal. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res 1998;795(1-2):197-203.
43. Ma W, Bisby MA. Partial and complete sciatic nerve injuries induce similar increases of neuropeptide Y and vasoactive intestinal peptide immunoreactivities in primary sensory neurons and their central projections. Neuroscience 1998;86(4):1217-34.
44. Okamoto M, Baba H, Goldstein PA, etal. Functional reorganization of sensory pathways in the rat spinal dorsal horn following peripheral nerve injury. J Physiol 2001;532(Pt 1):241-50.
45. Kim H, Clark D, Dionne RA. Genetic contributions to clinical pain and analgesia: Avoiding pitfalls in genetic research. J Pain 2009;10(7):663-93.
46. Young EE, Lariviere WR, Belfer I. Genetic basis of pain variability: Recent advances. J Med Genet 2011;49(1):1-9.
47. Kim H, Dionne RA. Individualized pain medicine. Drug Discov Today Ther Strateg 2009;6(3):83-7.
48. Muralidharan A, Smith MT. Pain, analgesia and genetics. J Pharm Pharmacol 2011;63(11):1387-400.
49. Buskila D, Sarzi-Puttini P, Ablin JN. The genetics of fibromyalgia syndrome. Pharmacogenomics [Review]. 2007;8(1):67-74.
50. Diatchenko L, Slade GD, Nackley AG, etal. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005;14(1):135-43.
51. Armero P, Muriel C, Santos J, etal. COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population. Eur J Pain 2005;9(3):229-32.
52. Kim H, Lee H, Rowan J, Brahim J, Dionne RA. Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. Mol Pain 2006;2:24.
53. Nassar MA, Stirling LC, Forlani G, etal. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A 2004;101(34):12706-11.
54. Reimann F, Cox JJ, Belfer I, etal. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A 2010;107(11):5148-53.
55. Dib-Hajj SD, Yang Y, Waxman SG. Genetics and molecular pathophysiology of Na(v)1.7-related pain syndromes. Adv Genet 2008;63:85-110.
56. Cox JJ, Reimann F, Nicholas AK, etal. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006;444(7121):894-8.
57. Eichler EE, Flint J, Gibson G, etal. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010;11(6):446-50.
58. Clarke AJ, Cooper DN. GWAS: Heritability missing in action? Eur J Hum Genet 2010;18(8):859-61.
59. Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011;12(1):7-18.
60. Kouzarides T. Chromatin modifications and their function. Cell [Review]. 2007;128(4):693-705.
61. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev [Review]. 1998;12(5):599-606.
62. Bollati V, Baccarelli A. Environmental epigenetics. Heredity 2010;105(1):105-12.
63. Comb M, Goodman HM. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 1990;18(13):3975-82.
64. Watt F, Molloy PL. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev 1988;2(9):1136-43.
65. Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997;88(4):471-81.
66. Boyes J, Bird A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 1991;64(6):1123-34.
67. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992;69(6):915-26.
68. Ehrlich M, Gama-Sosa MA, Huang LH, etal. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res 1982;10(8):2709-21.
69. Chen ZX, Riggs AD. DNA methylation and demethylation in mammals. J Biol Chem 2011;286(21):18347-53.
70. Bird A. Perceptions of epigenetics. Nature 2007;447(7143):396-8.
71. Ku CS, Naidoo N, Wu M, Soong R. Studying the epigenome using next generation sequencing. J Med Genet 2011;48(11):721-30.
72. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron 2007;53(6):857-69.
73. Hsieh CL. Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 1994;14(8):5487-94.
74. Lubbert M, Oster W, Ludwig WD, etal. A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias. Blood 1992;80(8):2066-73.
75. Grayson DR, Jia X, Chen Y, etal. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 2005;102(26):9341-6.
76. Nielsen DA, Yuferov V, Hamon S, etal. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 2009;34(4):867-73.
77. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005;308(5727):1466-9.
78. Liang R, Bates DJ, Wang E. Epigenetic control of microRNA expression and aging. Curr Genomics 2009;10(3):184-93.
79. Rassoulzadegan M, Grandjean V, Gounon P, etal. RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature 2006;441(7092):469-74.
80. Dorn G, Patel S, Wotherspoon G, etal. siRNA relieves chronic neuropathic pain. Nucleic Acids Res 2004;32(5):e49.
81. McBride JL, Pitzer MR, Boudreau RL, etal. Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for huntington's disease. Mol Ther 2011;19(12):2152-62.
82. Wang Z, Rao DD, Senzer N, Nemunaitis J. RNA interference and cancer therapy. Pharm Res 2011;28(12):2983-95.
83. Time for the epigenome. Nature 2010;463(7281):587.
84. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011;12(8):529-41.
85. Bernstein BE, Stamatoyannopoulos JA, Costello JF, etal. The NIH roadmap epigenomics mapping consortium. Nat Biotechnol 2010;28(10):1045-8.
86. Yuferov V, Nielsen DA, Levran O, etal. Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs. Pharmacogenet Genomics [Research Support, N.I.H., Extramural]. 2011 Apr;21(4):185-96.
87. Solomon MJ, Larsen PL, Varshavsky A. Mapping protein-DNA interactions in vivo with formaldehyde: Evidence that histone H4 is retained on a highly transcribed gene. Cell 1988;53(6):937-47.
88. Huang YM, Wang CM, Wang CT, etal. Perioperative celecoxib administration for pain management after total knee arthroplasty-A randomized, controlled study. BMC Musculoskelet Disord 2008;9:77.
89. Ilfeld BM, Meyer RS, Le LT, etal. Health-related quality of life after tricompartment knee arthroplasty with and without an extended-duration continuous femoral nerve block: A prospective, 1-year follow-up of a randomized, triple-masked, placebo-controlled study. Anesth Analg 2009;108(4):1320-5.
90. Eisenach JC. Preventing chronic pain after surgery: Who, how, and when? Reg Anesth Pain Med 2006;31(1):1-3.
91. Richman JM, Liu SS, Courpas G, etal. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg 2006;102(1):248-57.
92. Nikolajsen L, Ilkjaer S, Christensen JH, Kroner K, Jensen TS. Randomised trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation. Lancet 1997;350(9088):1353-7.
93. Hayes C, Armstrong-Brown A, Burstal R. Perioperative intravenous ketamine infusion for the prevention of persistent post-amputation pain: A randomized, controlled trial. Anaesth Intensive Care 2004;32(3):330-8.
94. Elizaga AM, Smith DG, Sharar SR, Edwards WT, Hansen ST, Jr. Continuous regional analgesia by intraneural block: Effect on postoperative opioid requirements and phantom limb pain following amputation. J Rehabil Res Dev 1994;31(3):179-87.
95. Ypsilantis E, Tang TY. Pre-emptive analgesia for chronic limb pain after amputation for peripheral vascular disease: A systematic review. Ann Vasc Surg 2010;24(8):1139-46.
96. Joshi GP, Bonnet F, Shah R, etal. A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia. Anesth Analg 2008;107(3):1026-40.
97. Lee YS, Kim H, Wu TX, Wang XM, Dionne RA. Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. Clin Pharmacol Ther 2006;79(5):407-18.
98. Hammer P, Banck MS, Amberg R, etal. mRNA-seq with agnostic splice site discovery for nervous system transcriptomics tested in chronic pain. Genome Res 2010;20(6):847-60.
99. Hashimoto K, Oreffo RO, Gibson MB, Goldring MB, Roach HI. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum 2009;60(11):3303-13.
100. Su RC, Becker AB, Kozyrskyj AL, Hayglass KT. Epigenetic regulation of established human type 1 versus type 2 cytokine responses. J Allergy Clin Immunol 2008;121(1):57-63.
101. Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 1992;35(7):740-4.
102. Geiss A, Rohleder N, Anton F. Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology 2012;37(5):671-84.
103. Turner JD, Pelascini LP, Macedo JA, Muller CP. Highly individual methylation patterns of alternative glucocorticoid receptor promoters suggest individualized epigenetic regulatory mechanisms. Nucleic Acids Res 2008;36(22):7207-18.
104. Zhang Z, Cai YQ, Zou F, Bie B, Pan ZZ. Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 2011;17(11):1448-55.
105. Viet CT, Ye Y, Dang D, etal. Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain. Pain 2011;152(10):2323-32.
106. Goh L, Samanta A. A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis. Rheumatol Int 2009;29(10):1123-35.
107. Reed MR, Taylor AL. Tumour necrosis factor inhibitors in ankylosing spondylitis. Intern Med J 2008;38(10):781-9.
108. Sommer C, Schafers M, Marziniak M, Toyka KV. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 2001;6(2):67-72.
109. Dogrul A, Gul H, Yesilyurt O, Ulas UH, Yildiz O. Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice. Acta Diabetol 2011;48(2):135-42.
110. Kleinschnitz C, Hofstetter HH, Meuth SG, etal. T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol 2006;200(2):480-5.
111. Ribeiro RA, Vale ML, Thomazzi SM, etal. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 2000;387(1):111-8.
112. Barclay J, Clark AK, Ganju P, etal. Role of the cysteine protease cathepsin S in neuropathic hyperalgesia. Pain 2007;130(3):225-34.
113. Ting E, Guerrero AT, Cunha TM, etal. Role of complement C5a in mechanical inflammatory hypernociception: Potential use of C5a receptor antagonists to control inflammatory pain. Br J Pharmacol 2008;153(5):1043-53.
114. Yun JM, Jialal I, Devaraj S. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem 2011;22(5):450-8.
115. Ke J, Long X, Liu Y, etal. Role of NF-kappaB in TNF-alpha-induced COX-2 expression in synovial fibroblasts from human TMJ. J Dent Res 2007;86(4):363-7.
116. Ito K, Lim S, Caramori G, etal. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001;15(6):1110-2.
117. Kiernan R, Bres V, Ng RW, etal. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 2003;278(4):2758-66.
118. Kirillov A, Kistler B, Mostoslavsky R, etal. A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat Genet 1996;13(4):435-41.
119. Imagawa K, de Andres MC, Hashimoto K, etal. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes-Implications for osteoarthritis. Biochem Biophys Res Commun 2011;405(3):362-7.
120. Kaltschmidt B, Kaltschmidt C. NF-kappaB in the nervous system. Cold Spring Harb Perspect Biol 2009;1(3):a001271.
121. Fu ES, Zhang YP, Sagen J, etal. Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain 2010;148(3):509-18.
122. Montagna P. The primary headaches: Genetics, epigenetics and a behavioural genetic model. J Headache Pain 2008;9(2):57-69.
123. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21(1):55-89.
124. Chen P, Jiang T, Ouyang J, Cui Y, Chen Y. Epigenetic programming of diverse glucocorticoid response and inflammatory/immune-mediated disease. Med Hypotheses 2009;73(5):657-8.
125. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1987;1(1):68-74.
126. Hearing SD, Norman M, Smyth C, Foy C, Dayan CM. Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab 1999;84(11):4149-54.
127. Lillycrop KA, Slater-Jefferies JL, Hanson MA, etal. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 2007;97(6):1064-73.
128. Meaney MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci [Review]. 2001;24:1161-92.
129. Rivarola MA, Suarez MM. Early maternal separation and chronic variable stress in adulthood changes the neural activity and the expression of glucocorticoid receptor in limbic structures. Int J Dev Neurosci 2009;27(6):567-74.
130. Uys JD, Muller CJ, Marais L, etal. Early life trauma decreases glucocorticoid receptors in rat dentate gyrus upon adult re-stress: Reversal by escitalopram. Neuroscience 2006;137(2):619-25.
131. McGowan PO, Sasaki A, D'Alessio AC, etal. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009;12(3):342-8.
132. Diorio J, Meaney MJ. Maternal programming of defensive responses through sustained effects on gene expression. J Psychiatry Neurosci 2007;32(4):275-84.
133. Miller G, Chen E. Unfavorable socioeconomic conditions in early life presage expression of proinflammatory phenotype in adolescence. Psychosom Med 2007;69(5):402-9.
134. van Everdingen AA, Huisman AM, Wenting MJ, etal. Down regulation of glucocorticoid receptors in early-diagnosed rheumatoid arthritis. Clin Exp Rheumatol 2002;20(4):463-8.
135. Lentjes EG, Griep EN, Boersma JW, Romijn FP, de Kloet ER. Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology 1997;22(8):603-14.
136. Francis D, Diorio J, Liu D, Meaney MJ. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 1999;286(5442):1155-8.
137. Hwang CK, Song KY, Kim CS, etal. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol 2007;27(13):4720-36.
138. Lim G, Wang S, Zeng Q, Sung B, Mao J. Spinal glucocorticoid receptors contribute to the development of morphine tolerance in rats. Anesthesiology 2005;102(4):832-7.
139. Wang S, Lim G, Zeng Q, etal. Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 2004;24(39):8595-605.
140. Low LA, Schweinhardt P. Early life adversity as a risk factor for fibromyalgia in later life. Pain Res Treat 2012;2012:140832.
141. Miranda A. Early life stress and pain: An important link to functional bowel disorders. Pediatr Ann 2009;38(5):279-82.
142. Davis DA, Luecken LJ, Zautra AJ. Are reports of childhood abuse related to the experience of chronic pain in adulthood? A meta-analytic review of the literature. Clin J Pain 2005;21(5):398-405.
143. Green PG, Chen X, Alvarez P, Ferrari LF, Levine JD. Early-life stress produces muscle hyperalgesia and nociceptor sensitization in the adult rat. Pain 2011;152(11):2549-56.
144. Lotsch J, Geisslinger G, Tegeder I. Genetic modulation of the pharmacological treatment of pain. Pharmacol Ther 2009;124(2):168-84.
145. Ishizawar D, Yancy C. Racial differences in heart failure therapeutics. Heart Fail Clin 2010;6(1):65-74.
146. Sadowska AM, Nowe V, Janssens A, etal. Customizing systemic therapy in patients with advanced non-small cell lung cancer. Ther Adv Med Oncol 2011;3(4):207-18.
147. Weitzel JN, Blazer KR, Macdonald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin 2011;61(5):327-59.
148. Rodriguez-Menendez V, Tremolizzo L, Cavaletti G. Targeting cancer and neuropathy with histone deacetylase inhibitors: Two birds with one stone? Curr Cancer Drug Targets 2008;8(4):266-74.
149. Sowa Y, Orita T, Minamikawa S, etal. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun 1997;241(1):142-50.
150. Prince HM, Bishton MJ, Harrison SJ. Clinical studies of histone deacetylase inhibitors. Clin Cancer Res 2009;15(12):3958-69.
151. Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 2009;49:243-63.
152. Duvic M, Vu J. Vorinostat: A new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opin Investig Drugs 2007;16(7):1111-20.
153. Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai LH. Recovery of learning and memory is associated with chromatin remodelling. Nature [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. 2007;447(7141):178-82.
154. Chiechio S, Zammataro M, Morales ME, etal. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol 2009;75(5):1014-20.
155. Chung YL, Lee MY, Wang AJ, Yao LF. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther 2003;8(5):707-17.
156. Leoni F, Zaliani A, Bertolini G, etal. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci U S A 2002;99(5):2995-3000.
157. Lu Y, Nie J, Liu X, Zheng Y, Guo SW. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod 2010;25(4):1014-25.
158. Jones CK, Eberle EL, Peters SC, Monn JA, Shannon HE. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing. Neuropharmacology 2005;49(suppl 1):206-18.
159. Lin YC, Flock KE, Cook RJ, etal. Effects of trichostatin A on neuronal mu-opioid receptor gene expression. Brain Res 2008;30(1246):1-10.
160. Vojinovic J, Damjanov N, D'Urzo C, etal. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2011;63(5):1452-8.
161. Phiel CJ, Zhang F, Huang EY, etal. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001;276(39):36734-41.
162. Bai G, Wei D, Zou S, Ren K, Dubner R. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Mol Pain 2010;6:51.
163. Agrawal RP, Goswami J, Jain S, Kochar DK. Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo-controlled study. Diabetes Res Clin Pract 2009;83(3):371-8.
164. Freitag FG, Diamond S, Diamond ML, Urban GJ. Divalproex in the long-term treatment of chronic daily headache. Headache 2001;41(3):271-8.
165. Capuano A, Vollono C, Mei D, etal. Antiepileptic drugs in migraine prophylaxis: State of the art. Clin Ter 2004;155(2-3):79-87.
166. Chiba T, Yokosuka O, Arai M, etal. Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. J Hepatol 2004;41(3):436-45.
167. Lee HS, Park MH, Yang SJ, etal. Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray. Biol Pharm Bull 2004;27(10):1497-503.
168. Rajan I, Savelieva KV, Ye GL, etal. Loss of the putative catalytic domain of HDAC4 leads to reduced thermal nociception and seizures while allowing normal bone development. PLoS ONE 2009;4(8):e6612.
169. Black C, Clar C, Henderson R, etal. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: A systematic review and economic evaluation. Health Technol Assess [Review]. 2009;13(52):1-148.
170. Largo R, Alvarez-Soria MA, Diez-Ortego I, etal. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2003;11(4):290-8.
171. Detich N, Bovenzi V, Szyf M. Valproate induces replication-independent active DNA demethylation. J Biol Chem 2003;278(30):27586-92.
172. Dong E, Guidotti A, Grayson DR, Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci U S A 2007;104(11):4676-81.
173. Villeda SA, Akopians AL, Babayan AH, Basbaum AI, Phelps PE. Absence of Reelin results in altered nociception and aberrant neuronal positioning in the dorsal spinal cord. Neuroscience 2006;139(4):1385-96.
174. Chen Y, Beffert U, Ertunc M, etal. Reelin modulates NMDA receptor activity in cortical neurons. J Neurosci 2005;25(36):8209-16.
175. Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DR. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J Neurochem 2005;93(2):483-92.
176. Weaver IC, Champagne FA, Brown SE, etal. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. J Neurosci 2005;25(47):11045-54.
177. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002;132(8 suppl):2393S-400S.
178. Waterhouse PM, Wang MB, Lough T. Gene silencing as an adaptive defence against viruses. Nature [Review]. 2001;411(6839):834-42.
179. McCaffrey AP, Meuse L, Pham TT, etal. RNA interference in adult mice. Nature 2002;418(6893):38-9.
180. Tan PH, Yang LC, Shih HC, Lan KC, Cheng JT. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther 2005;12(1):59-66.
181. Garraway SM, Xu Q, Inturrisi CE. Design and evaluation of small interfering RNAs that target expression of the N-methyl-D-aspartate receptor NR1 subunit gene in the spinal cord dorsal horn. J Pharmacol Exp Ther 2007;322(3):982-8.
182. Kasama S, Kawakubo M, Suzuki T, etal. A interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat. Eur J Neurosci 2007;25(10):2956-63.
183. Guo W, Robbins MT, Wei F, etal. Supraspinal brain-derived neurotrophic factor signaling: A novel mechanism for descending pain facilitation. J Neurosci 2006;26(1):126-37.
184. Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003;327(4):761-6.